JP5571561B2 - 医薬品吸入装置及びそれらの構成要素 - Google Patents

医薬品吸入装置及びそれらの構成要素 Download PDF

Info

Publication number
JP5571561B2
JP5571561B2 JP2010533235A JP2010533235A JP5571561B2 JP 5571561 B2 JP5571561 B2 JP 5571561B2 JP 2010533235 A JP2010533235 A JP 2010533235A JP 2010533235 A JP2010533235 A JP 2010533235A JP 5571561 B2 JP5571561 B2 JP 5571561B2
Authority
JP
Japan
Prior art keywords
item
coating
group
component
metallic coating
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Fee Related
Application number
JP2010533235A
Other languages
English (en)
Japanese (ja)
Other versions
JP2011502646A5 (enExample
JP2011502646A (ja
Inventor
エー. ジンクス,フィリップ
エム. デイビッド,モーゼス
イェー. ダムス,ルドルフ
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
3M Innovative Properties Co
Original Assignee
3M Innovative Properties Co
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by 3M Innovative Properties Co filed Critical 3M Innovative Properties Co
Publication of JP2011502646A publication Critical patent/JP2011502646A/ja
Publication of JP2011502646A5 publication Critical patent/JP2011502646A5/ja
Application granted granted Critical
Publication of JP5571561B2 publication Critical patent/JP5571561B2/ja
Expired - Fee Related legal-status Critical Current
Anticipated expiration legal-status Critical

Links

Images

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61MDEVICES FOR INTRODUCING MEDIA INTO, OR ONTO, THE BODY; DEVICES FOR TRANSDUCING BODY MEDIA OR FOR TAKING MEDIA FROM THE BODY; DEVICES FOR PRODUCING OR ENDING SLEEP OR STUPOR
    • A61M16/00Devices for influencing the respiratory system of patients by gas treatment, e.g. ventilators; Tracheal tubes
    • A61M16/10Preparation of respiratory gases or vapours
    • A61M16/14Preparation of respiratory gases or vapours by mixing different fluids, one of them being in a liquid phase
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61MDEVICES FOR INTRODUCING MEDIA INTO, OR ONTO, THE BODY; DEVICES FOR TRANSDUCING BODY MEDIA OR FOR TAKING MEDIA FROM THE BODY; DEVICES FOR PRODUCING OR ENDING SLEEP OR STUPOR
    • A61M15/00Inhalators
    • A61M15/009Inhalators using medicine packages with incorporated spraying means, e.g. aerosol cans
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61MDEVICES FOR INTRODUCING MEDIA INTO, OR ONTO, THE BODY; DEVICES FOR TRANSDUCING BODY MEDIA OR FOR TAKING MEDIA FROM THE BODY; DEVICES FOR PRODUCING OR ENDING SLEEP OR STUPOR
    • A61M11/00Sprayers or atomisers specially adapted for therapeutic purposes
    • A61M11/04Sprayers or atomisers specially adapted for therapeutic purposes operated by the vapour pressure of the liquid to be sprayed or atomised
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61MDEVICES FOR INTRODUCING MEDIA INTO, OR ONTO, THE BODY; DEVICES FOR TRANSDUCING BODY MEDIA OR FOR TAKING MEDIA FROM THE BODY; DEVICES FOR PRODUCING OR ENDING SLEEP OR STUPOR
    • A61M15/00Inhalators
    • A61M15/0065Inhalators with dosage or measuring devices
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61MDEVICES FOR INTRODUCING MEDIA INTO, OR ONTO, THE BODY; DEVICES FOR TRANSDUCING BODY MEDIA OR FOR TAKING MEDIA FROM THE BODY; DEVICES FOR PRODUCING OR ENDING SLEEP OR STUPOR
    • A61M15/00Inhalators
    • A61M15/0086Inhalation chambers
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61MDEVICES FOR INTRODUCING MEDIA INTO, OR ONTO, THE BODY; DEVICES FOR TRANSDUCING BODY MEDIA OR FOR TAKING MEDIA FROM THE BODY; DEVICES FOR PRODUCING OR ENDING SLEEP OR STUPOR
    • A61M15/00Inhalators
    • A61M15/0091Inhalators mechanically breath-triggered
    • BPERFORMING OPERATIONS; TRANSPORTING
    • B05SPRAYING OR ATOMISING IN GENERAL; APPLYING FLUENT MATERIALS TO SURFACES, IN GENERAL
    • B05DPROCESSES FOR APPLYING FLUENT MATERIALS TO SURFACES, IN GENERAL
    • B05D1/00Processes for applying liquids or other fluent materials
    • B05D1/62Plasma-deposition of organic layers
    • BPERFORMING OPERATIONS; TRANSPORTING
    • B05SPRAYING OR ATOMISING IN GENERAL; APPLYING FLUENT MATERIALS TO SURFACES, IN GENERAL
    • B05DPROCESSES FOR APPLYING FLUENT MATERIALS TO SURFACES, IN GENERAL
    • B05D5/00Processes for applying liquids or other fluent materials to surfaces to obtain special surface effects, finishes or structures
    • B05D5/08Processes for applying liquids or other fluent materials to surfaces to obtain special surface effects, finishes or structures to obtain an anti-friction or anti-adhesive surface
    • B05D5/083Processes for applying liquids or other fluent materials to surfaces to obtain special surface effects, finishes or structures to obtain an anti-friction or anti-adhesive surface involving the use of fluoropolymers
    • BPERFORMING OPERATIONS; TRANSPORTING
    • B05SPRAYING OR ATOMISING IN GENERAL; APPLYING FLUENT MATERIALS TO SURFACES, IN GENERAL
    • B05DPROCESSES FOR APPLYING FLUENT MATERIALS TO SURFACES, IN GENERAL
    • B05D5/00Processes for applying liquids or other fluent materials to surfaces to obtain special surface effects, finishes or structures
    • B05D5/08Processes for applying liquids or other fluent materials to surfaces to obtain special surface effects, finishes or structures to obtain an anti-friction or anti-adhesive surface
    • B05D5/083Processes for applying liquids or other fluent materials to surfaces to obtain special surface effects, finishes or structures to obtain an anti-friction or anti-adhesive surface involving the use of fluoropolymers
    • B05D5/086Processes for applying liquids or other fluent materials to surfaces to obtain special surface effects, finishes or structures to obtain an anti-friction or anti-adhesive surface involving the use of fluoropolymers having an anchoring layer
    • BPERFORMING OPERATIONS; TRANSPORTING
    • B65CONVEYING; PACKING; STORING; HANDLING THIN OR FILAMENTARY MATERIAL
    • B65DCONTAINERS FOR STORAGE OR TRANSPORT OF ARTICLES OR MATERIALS, e.g. BAGS, BARRELS, BOTTLES, BOXES, CANS, CARTONS, CRATES, DRUMS, JARS, TANKS, HOPPERS, FORWARDING CONTAINERS; ACCESSORIES, CLOSURES, OR FITTINGS THEREFOR; PACKAGING ELEMENTS; PACKAGES
    • B65D83/00Containers or packages with special means for dispensing contents
    • B65D83/14Containers for dispensing liquid or semi-liquid contents by internal gaseous pressure, i.e. aerosol containers comprising propellant
    • B65D83/44Valves specially adapted for the discharge of contents; Regulating devices
    • B65D83/52Metering valves; Metering devices
    • CCHEMISTRY; METALLURGY
    • C23COATING METALLIC MATERIAL; COATING MATERIAL WITH METALLIC MATERIAL; CHEMICAL SURFACE TREATMENT; DIFFUSION TREATMENT OF METALLIC MATERIAL; COATING BY VACUUM EVAPORATION, BY SPUTTERING, BY ION IMPLANTATION OR BY CHEMICAL VAPOUR DEPOSITION, IN GENERAL; INHIBITING CORROSION OF METALLIC MATERIAL OR INCRUSTATION IN GENERAL
    • C23CCOATING METALLIC MATERIAL; COATING MATERIAL WITH METALLIC MATERIAL; SURFACE TREATMENT OF METALLIC MATERIAL BY DIFFUSION INTO THE SURFACE, BY CHEMICAL CONVERSION OR SUBSTITUTION; COATING BY VACUUM EVAPORATION, BY SPUTTERING, BY ION IMPLANTATION OR BY CHEMICAL VAPOUR DEPOSITION, IN GENERAL
    • C23C16/00Chemical coating by decomposition of gaseous compounds, without leaving reaction products of surface material in the coating, i.e. chemical vapour deposition [CVD] processes
    • C23C16/02Pretreatment of the material to be coated
    • C23C16/0227Pretreatment of the material to be coated by cleaning or etching
    • C23C16/0245Pretreatment of the material to be coated by cleaning or etching by etching with a plasma
    • CCHEMISTRY; METALLURGY
    • C23COATING METALLIC MATERIAL; COATING MATERIAL WITH METALLIC MATERIAL; CHEMICAL SURFACE TREATMENT; DIFFUSION TREATMENT OF METALLIC MATERIAL; COATING BY VACUUM EVAPORATION, BY SPUTTERING, BY ION IMPLANTATION OR BY CHEMICAL VAPOUR DEPOSITION, IN GENERAL; INHIBITING CORROSION OF METALLIC MATERIAL OR INCRUSTATION IN GENERAL
    • C23CCOATING METALLIC MATERIAL; COATING MATERIAL WITH METALLIC MATERIAL; SURFACE TREATMENT OF METALLIC MATERIAL BY DIFFUSION INTO THE SURFACE, BY CHEMICAL CONVERSION OR SUBSTITUTION; COATING BY VACUUM EVAPORATION, BY SPUTTERING, BY ION IMPLANTATION OR BY CHEMICAL VAPOUR DEPOSITION, IN GENERAL
    • C23C16/00Chemical coating by decomposition of gaseous compounds, without leaving reaction products of surface material in the coating, i.e. chemical vapour deposition [CVD] processes
    • C23C16/22Chemical coating by decomposition of gaseous compounds, without leaving reaction products of surface material in the coating, i.e. chemical vapour deposition [CVD] processes characterised by the deposition of inorganic material, other than metallic material
    • C23C16/26Deposition of carbon only
    • CCHEMISTRY; METALLURGY
    • C23COATING METALLIC MATERIAL; COATING MATERIAL WITH METALLIC MATERIAL; CHEMICAL SURFACE TREATMENT; DIFFUSION TREATMENT OF METALLIC MATERIAL; COATING BY VACUUM EVAPORATION, BY SPUTTERING, BY ION IMPLANTATION OR BY CHEMICAL VAPOUR DEPOSITION, IN GENERAL; INHIBITING CORROSION OF METALLIC MATERIAL OR INCRUSTATION IN GENERAL
    • C23CCOATING METALLIC MATERIAL; COATING MATERIAL WITH METALLIC MATERIAL; SURFACE TREATMENT OF METALLIC MATERIAL BY DIFFUSION INTO THE SURFACE, BY CHEMICAL CONVERSION OR SUBSTITUTION; COATING BY VACUUM EVAPORATION, BY SPUTTERING, BY ION IMPLANTATION OR BY CHEMICAL VAPOUR DEPOSITION, IN GENERAL
    • C23C16/00Chemical coating by decomposition of gaseous compounds, without leaving reaction products of surface material in the coating, i.e. chemical vapour deposition [CVD] processes
    • C23C16/22Chemical coating by decomposition of gaseous compounds, without leaving reaction products of surface material in the coating, i.e. chemical vapour deposition [CVD] processes characterised by the deposition of inorganic material, other than metallic material
    • C23C16/30Deposition of compounds, mixtures or solid solutions, e.g. borides, carbides, nitrides
    • CCHEMISTRY; METALLURGY
    • C23COATING METALLIC MATERIAL; COATING MATERIAL WITH METALLIC MATERIAL; CHEMICAL SURFACE TREATMENT; DIFFUSION TREATMENT OF METALLIC MATERIAL; COATING BY VACUUM EVAPORATION, BY SPUTTERING, BY ION IMPLANTATION OR BY CHEMICAL VAPOUR DEPOSITION, IN GENERAL; INHIBITING CORROSION OF METALLIC MATERIAL OR INCRUSTATION IN GENERAL
    • C23CCOATING METALLIC MATERIAL; COATING MATERIAL WITH METALLIC MATERIAL; SURFACE TREATMENT OF METALLIC MATERIAL BY DIFFUSION INTO THE SURFACE, BY CHEMICAL CONVERSION OR SUBSTITUTION; COATING BY VACUUM EVAPORATION, BY SPUTTERING, BY ION IMPLANTATION OR BY CHEMICAL VAPOUR DEPOSITION, IN GENERAL
    • C23C16/00Chemical coating by decomposition of gaseous compounds, without leaving reaction products of surface material in the coating, i.e. chemical vapour deposition [CVD] processes
    • C23C16/22Chemical coating by decomposition of gaseous compounds, without leaving reaction products of surface material in the coating, i.e. chemical vapour deposition [CVD] processes characterised by the deposition of inorganic material, other than metallic material
    • C23C16/30Deposition of compounds, mixtures or solid solutions, e.g. borides, carbides, nitrides
    • C23C16/40Oxides
    • C23C16/401Oxides containing silicon
    • CCHEMISTRY; METALLURGY
    • C23COATING METALLIC MATERIAL; COATING MATERIAL WITH METALLIC MATERIAL; CHEMICAL SURFACE TREATMENT; DIFFUSION TREATMENT OF METALLIC MATERIAL; COATING BY VACUUM EVAPORATION, BY SPUTTERING, BY ION IMPLANTATION OR BY CHEMICAL VAPOUR DEPOSITION, IN GENERAL; INHIBITING CORROSION OF METALLIC MATERIAL OR INCRUSTATION IN GENERAL
    • C23CCOATING METALLIC MATERIAL; COATING MATERIAL WITH METALLIC MATERIAL; SURFACE TREATMENT OF METALLIC MATERIAL BY DIFFUSION INTO THE SURFACE, BY CHEMICAL CONVERSION OR SUBSTITUTION; COATING BY VACUUM EVAPORATION, BY SPUTTERING, BY ION IMPLANTATION OR BY CHEMICAL VAPOUR DEPOSITION, IN GENERAL
    • C23C16/00Chemical coating by decomposition of gaseous compounds, without leaving reaction products of surface material in the coating, i.e. chemical vapour deposition [CVD] processes
    • C23C16/56After-treatment
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61MDEVICES FOR INTRODUCING MEDIA INTO, OR ONTO, THE BODY; DEVICES FOR TRANSDUCING BODY MEDIA OR FOR TAKING MEDIA FROM THE BODY; DEVICES FOR PRODUCING OR ENDING SLEEP OR STUPOR
    • A61M15/00Inhalators
    • A61M15/08Inhaling devices inserted into the nose
    • BPERFORMING OPERATIONS; TRANSPORTING
    • B05SPRAYING OR ATOMISING IN GENERAL; APPLYING FLUENT MATERIALS TO SURFACES, IN GENERAL
    • B05DPROCESSES FOR APPLYING FLUENT MATERIALS TO SURFACES, IN GENERAL
    • B05D2202/00Metallic substrate
    • B05D2202/10Metallic substrate based on Fe
    • B05D2202/15Stainless steel
    • YGENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10TECHNICAL SUBJECTS COVERED BY FORMER USPC
    • Y10TTECHNICAL SUBJECTS COVERED BY FORMER US CLASSIFICATION
    • Y10T428/00Stock material or miscellaneous articles
    • Y10T428/26Web or sheet containing structurally defined element or component, the element or component having a specified physical dimension
    • Y10T428/263Coating layer not in excess of 5 mils thick or equivalent
    • Y10T428/264Up to 3 mils
    • Y10T428/2651 mil or less
    • YGENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10TECHNICAL SUBJECTS COVERED BY FORMER USPC
    • Y10TTECHNICAL SUBJECTS COVERED BY FORMER US CLASSIFICATION
    • Y10T428/00Stock material or miscellaneous articles
    • Y10T428/31504Composite [nonstructural laminate]
    • Y10T428/31652Of asbestos
    • Y10T428/31663As siloxane, silicone or silane
    • YGENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10TECHNICAL SUBJECTS COVERED BY FORMER USPC
    • Y10TTECHNICAL SUBJECTS COVERED BY FORMER US CLASSIFICATION
    • Y10T428/00Stock material or miscellaneous articles
    • Y10T428/31504Composite [nonstructural laminate]
    • Y10T428/31652Of asbestos
    • Y10T428/31667Next to addition polymer from unsaturated monomers, or aldehyde or ketone condensation product

Landscapes

  • Chemical & Material Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Health & Medical Sciences (AREA)
  • Mechanical Engineering (AREA)
  • General Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Metallurgy (AREA)
  • Materials Engineering (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Anesthesiology (AREA)
  • Biomedical Technology (AREA)
  • General Health & Medical Sciences (AREA)
  • Hematology (AREA)
  • Pulmonology (AREA)
  • Inorganic Chemistry (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Plasma & Fusion (AREA)
  • Physics & Mathematics (AREA)
  • Dispersion Chemistry (AREA)
  • Emergency Medicine (AREA)
  • Biophysics (AREA)
  • Application Of Or Painting With Fluid Materials (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicinal Preparation (AREA)
  • Paints Or Removers (AREA)
  • Chemical Vapour Deposition (AREA)
JP2010533235A 2007-11-06 2008-11-06 医薬品吸入装置及びそれらの構成要素 Expired - Fee Related JP5571561B2 (ja)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US98574107P 2007-11-06 2007-11-06
US60/985,741 2007-11-06
PCT/US2008/082600 WO2009061895A2 (en) 2007-11-06 2008-11-06 Medicinal inhalation devices and components thereof

Publications (3)

Publication Number Publication Date
JP2011502646A JP2011502646A (ja) 2011-01-27
JP2011502646A5 JP2011502646A5 (enExample) 2011-12-22
JP5571561B2 true JP5571561B2 (ja) 2014-08-13

Family

ID=40626431

Family Applications (2)

Application Number Title Priority Date Filing Date
JP2010533235A Expired - Fee Related JP5571561B2 (ja) 2007-11-06 2008-11-06 医薬品吸入装置及びそれらの構成要素
JP2010533232A Expired - Fee Related JP5571560B2 (ja) 2007-11-06 2008-11-06 医薬品吸入装置及びそれらの構成要素

Family Applications After (1)

Application Number Title Priority Date Filing Date
JP2010533232A Expired - Fee Related JP5571560B2 (ja) 2007-11-06 2008-11-06 医薬品吸入装置及びそれらの構成要素

Country Status (8)

Country Link
US (3) US8414956B2 (enExample)
EP (2) EP2205302A4 (enExample)
JP (2) JP5571561B2 (enExample)
CN (2) CN101909684B (enExample)
AU (2) AU2008323924B2 (enExample)
BR (2) BRPI0817384A2 (enExample)
CA (2) CA2704985C (enExample)
WO (2) WO2009061895A2 (enExample)

Families Citing this family (75)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US9006175B2 (en) 1999-06-29 2015-04-14 Mannkind Corporation Potentiation of glucose elimination
US6923175B2 (en) 2002-03-20 2005-08-02 Mannkind Corporation Inhalation apparatus
CN101010305B (zh) 2004-08-20 2010-08-11 曼金德公司 二酮哌嗪合成的催化反应
BR122019022692B1 (pt) 2004-08-23 2023-01-10 Mannkind Corporation Composição terapêutica em pó seco contendo dicetopiperazina, pelo menos um tipo de cátion e um agente biologicamente ativo
KR101384456B1 (ko) 2005-09-14 2014-04-10 맨카인드 코포레이션 활성제에 대한 결정질 미립자 표면의 친화력의 증가를 기반으로 하는 약물 제제화의 방법
ES2647080T3 (es) 2006-02-22 2017-12-19 Mannkind Corporation Un método para mejorar las propiedades farmacéuticas de micropartículas que comprenden dicetopiperazina y un agente activo
JP4884180B2 (ja) * 2006-11-21 2012-02-29 東京エレクトロン株式会社 基板処理装置および基板処理方法
WO2011163272A1 (en) 2010-06-21 2011-12-29 Mannkind Corporation Dry powder drug delivery system and methods
GB0721737D0 (en) * 2007-11-06 2007-12-19 3M Innovative Properties Co Medicinal inhalation devices and components thereof
US8414956B2 (en) * 2007-11-06 2013-04-09 3M Innovative Properties Company Medicinal inhalation devices and components thereof
JP5570996B2 (ja) 2007-12-14 2014-08-13 エアロデザインズ インコーポレイテッド エアロゾル化可能な食料品の送達
US8485180B2 (en) 2008-06-13 2013-07-16 Mannkind Corporation Dry powder drug delivery system
DK2293833T3 (en) 2008-06-13 2016-05-23 Mannkind Corp DRY POWDER INHALER AND MEDICINAL ADMINISTRATION SYSTEM
CA2728523C (en) 2008-06-20 2020-03-10 Mannkind Corporation An interactive apparatus and method for real-time profiling of inhalation efforts
TWI532497B (zh) 2008-08-11 2016-05-11 曼凱公司 超快起作用胰島素之用途
US8314106B2 (en) 2008-12-29 2012-11-20 Mannkind Corporation Substituted diketopiperazine analogs for use as drug delivery agents
CA2754595C (en) 2009-03-11 2017-06-27 Mannkind Corporation Apparatus, system and method for measuring resistance of an inhaler
WO2010129753A1 (en) 2009-05-06 2010-11-11 3M Innovative Properties Company Medicinal inhalation device
US10410838B2 (en) 2009-05-06 2019-09-10 3M Innovative Properties Company Apparatus and method for plasma treatment of containers
US20120097159A1 (en) * 2009-05-06 2012-04-26 Suresh Iyer Medicinal inhalation devices and components thereof
US8551528B2 (en) 2009-06-12 2013-10-08 Mannkind Corporation Diketopiperazine microparticles with defined specific surface areas
JP5784622B2 (ja) 2009-11-03 2015-09-24 マンカインド コーポレ−ション 吸入活動をシミュレートするための装置及び方法
GB201003275D0 (en) * 2010-02-26 2010-04-14 Portal Medical Ltd Method of manufacturing a medicament dispenser device
GB201003273D0 (en) * 2010-02-26 2010-04-14 Portal Medical Ltd Medicament dispenser device
GB201016797D0 (en) * 2010-10-06 2010-11-17 British American Tobacco Co Aerosol generator
ES2625858T3 (es) 2011-04-01 2017-07-20 Mannkind Corporation Paquete de tipo blíster para cartuchos farmacéuticos
WO2012174472A1 (en) 2011-06-17 2012-12-20 Mannkind Corporation High capacity diketopiperazine microparticles
US9572596B2 (en) * 2011-06-30 2017-02-21 Covidien Lp Applicators for controlled in situ delivery of therapeutic compositions and implants, methods of fabrication and use
HK1201475A1 (en) 2011-10-24 2015-09-04 Mannkind Corporation Methods and compositions for treating pain
CA3098386C (en) 2012-07-12 2022-11-29 Mannkind Corporation Dry powder drug delivery systems and methods
DE102012110131A1 (de) 2012-10-24 2014-04-24 Schott Ag Verbundmaterial für ein pharmazeutisches Packmittel, Verfahren zu dessen Herstellung und Verwendung des Verbundmaterials
EP2911690A1 (en) 2012-10-26 2015-09-02 MannKind Corporation Inhalable influenza vaccine compositions and methods
GB201221063D0 (en) * 2012-11-23 2013-01-09 3M Innovative Properties Co Metered dose dispensing valve
MX369136B (es) 2013-03-15 2019-10-30 Mannkind Corp Composiciones de dicetopiperazina microcristalina y metodos.
JP6279222B2 (ja) * 2013-03-25 2018-02-14 スリーエム イノベイティブ プロパティズ カンパニー 摩擦係数の低い表面を有するポリマーを含む物品及びその製造方法
FR3006300B1 (fr) * 2013-06-04 2015-07-03 Aptar France Sas Valve doseuse et dispositif de distribution de produit fluide comportant une telle valve.
JP6373982B2 (ja) 2013-06-24 2018-08-15 スリーエム イノベイティブ プロパティズ カンパニー 研磨粒子、研磨粒子の作製方法、及び研磨物品
BR122019026637B1 (pt) 2013-07-18 2023-09-26 Mannkind Corporation Formulações farmacêuticas de pó seco e método para a fabricação de uma formulação de pó seco
US8962449B1 (en) * 2013-07-30 2015-02-24 Micron Technology, Inc. Methods for processing semiconductor devices
US11446127B2 (en) 2013-08-05 2022-09-20 Mannkind Corporation Insufflation apparatus and methods
EP3653207A1 (en) 2014-02-10 2020-05-20 Respivant Sciences GmbH Mast cell stabilizers treatment for systemic disorders
PL3104854T3 (pl) 2014-02-10 2020-11-30 Respivant Sciences Gmbh Stabilizatory komórek tucznych do leczenia choroby płuc
WO2015148905A1 (en) 2014-03-28 2015-10-01 Mannkind Corporation Use of ultrarapid acting insulin
US20170152396A1 (en) * 2014-05-22 2017-06-01 3M Innovative Properties Company Coating process
GB2536285A (en) * 2015-03-13 2016-09-14 3M Innovative Properties Co Coating process
WO2016018892A1 (en) 2014-07-29 2016-02-04 3M Innovative Properties Company Method of preparing a pharmaceutical composition
US10561806B2 (en) 2014-10-02 2020-02-18 Mannkind Corporation Mouthpiece cover for an inhaler
EP3331522A1 (en) 2015-08-07 2018-06-13 Patara Pharma LLC Methods for the treatment of mast cell related disorders with mast cell stabilizers
US10265296B2 (en) 2015-08-07 2019-04-23 Respivant Sciences Gmbh Methods for the treatment of systemic disorders treatable with mast cell stabilizers, including mast cell related disorders
KR20180052662A (ko) 2015-09-10 2018-05-18 임펠 뉴로파마 인코포레이티드 인-라인 코 전달 장치
EP3368083A1 (en) 2015-10-29 2018-09-05 3M Innovative Properties Company Formulation and aerosol canisters, inhalers, and the like containing the formulation
US9834713B2 (en) 2016-02-23 2017-12-05 3M Innovative Properties Company Oriented thermally conductive dielectric film
WO2018044942A1 (en) 2016-08-31 2018-03-08 Patara Pharma, LLC Cromolyn compositions for treatment of chronic cough due to idiopathic pulmonary fibrosis
CN109803724A (zh) 2016-10-07 2019-05-24 瑞思皮万特科学有限责任公司 用于治疗肺纤维化的色甘酸组合物
EP3624771B1 (en) 2017-05-17 2023-11-15 Kindeva Drug Delivery L.P. Method of maintaining a water level in a pressurized aerosol canister.
US11779716B2 (en) 2017-08-03 2023-10-10 Kindeva Drug Delivery L.P. Method for making medicinal delivery device having multi-layer coating
WO2019136291A1 (en) 2018-01-05 2019-07-11 Impel Neuropharma, Inc. Intranasal delivery of dihydroergotamine by precision olfactory device
EP3801479A1 (en) 2018-06-07 2021-04-14 Kindeva Drug Delivery L.P. Fluticasone and vilanterol formulation and inhaler
EP3801456A1 (en) 2018-06-07 2021-04-14 Kindeva Drug Delivery L.P. Fluticasone and vilanterol formulation and inhaler
US12220525B2 (en) 2018-06-27 2025-02-11 Kindeva Drug Deliver L.P. Tiotropium formulation and inhaler
EP3880169B1 (en) 2018-11-12 2025-07-23 Kindeva Drug Delivery L.P. Umeclidinium and vilanterol formulation and inhaler
EP3756711A1 (en) * 2019-06-25 2020-12-30 Presspart Gmbh & Co. Kg Method of plasma cleaning and coating of mdi cans
GB202011729D0 (en) * 2020-07-29 2020-09-09 Kindeva Drug Delivery Lp Device for delivery of a compound to a region of the nasal cavity
US12214346B2 (en) 2021-10-13 2025-02-04 Satio, Inc. Dermal patch with a diagnostic test strip
US12178979B2 (en) 2021-10-13 2024-12-31 Satio, Inc. Dermal patch for delivering a pharmaceutical
US12048543B2 (en) 2021-11-08 2024-07-30 Satio, Inc. Dermal patch for collecting a physiological sample with removable vial
US12053284B2 (en) 2021-11-08 2024-08-06 Satio, Inc. Dermal patch for collecting a physiological sample
US11964121B2 (en) 2021-10-13 2024-04-23 Satio, Inc. Mono dose dermal patch for pharmaceutical delivery
US11877848B2 (en) 2021-11-08 2024-01-23 Satio, Inc. Dermal patch for collecting a physiological sample
US12023156B2 (en) 2021-10-13 2024-07-02 Satio, Inc. Dermal patch for collecting a physiological sample
US12029562B2 (en) 2021-04-14 2024-07-09 Satio, Inc. Dermal patch system
MX2024002496A (es) 2021-09-08 2024-03-15 Kindeva Drug Delivery Lp Propulsores para agentes anticolinergicos en inhaladores de dosis medida presurizados.
WO2024181972A1 (en) 2022-03-01 2024-09-06 Kindeva Drug Delivery L.P. Metered dose inhalers and high-dose suspensions
WO2024182686A1 (en) 2023-03-02 2024-09-06 Kindeva Drug Delivery L.P. Metered dose inhalers and solutions including cannabinoids in hfa-152a
WO2024182699A1 (en) 2023-03-02 2024-09-06 Kindeva Drug Delivery L.P. Metered dose inhalers and solutions including cannabinoids in hfo-1234ze(e)

Family Cites Families (43)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3810874A (en) * 1969-03-10 1974-05-14 Minnesota Mining & Mfg Polymers prepared from poly(perfluoro-alkylene oxide) compounds
DE3832692A1 (de) * 1988-09-27 1990-03-29 Leybold Ag Dichtungselement mit einem absperrkoerper aus einem metallischen oder nichtmetallischen werkstoff und verfahren zum auftragen von hartstoffschichten auf den absperrkoerper
US6596260B1 (en) * 1993-08-27 2003-07-22 Novartis Corporation Aerosol container and a method for storage and administration of a predetermined amount of a pharmaceutically active aerosol
EP0813490B1 (en) * 1995-03-10 2000-07-12 Minnesota Mining And Manufacturing Company Aerosol valves
NZ306281A (en) 1995-04-14 1999-07-29 Glaxo Wellcome Inc Metered dose inhaler with part or all internal surfaces coated with fluorocarbon polymers for dispensing beclomethasone dipropionate
JPH11503352A (ja) 1995-04-14 1999-03-26 グラクソ、ウェルカム、インコーポレーテッド プロピオン酸フルチカゾン用計量投与用吸入器
AU710382B2 (en) 1995-04-14 1999-09-16 Glaxo Wellcome Inc. Metered dose inhaler for albuterol
AU718263B2 (en) 1995-04-14 2000-04-13 Smithkline Beecham Corporation Metered dose inhaler for salmeterol
CA2277977C (en) * 1997-02-04 2006-10-31 N.V. Bekaert S.A. A coating comprising layers of diamond like carbon and diamond like nanocomposite compositions
GB2329939A (en) 1997-06-26 1999-04-07 Glaxo Group Ltd Self-lubricating valve stem for aerosol containers
US20030103906A1 (en) * 1997-10-14 2003-06-05 Smithkline Beecham Corporation Metered dose inhaler having internal surfaces coated with fluorocarbon polymer
DK1208864T4 (da) 1998-02-23 2012-08-06 Glaxo Group Ltd Forbedringer til lægemiddelafgivelsesindretninger
EP1005917B1 (en) * 1998-12-01 2006-11-02 Microflow Engineering SA Inhaler with ultrasonic wave nebuliser having nozzle openings superposed on peaks of a standing wave pattern
DE19958336A1 (de) * 1999-12-03 2001-06-07 Inst Neue Mat Gemein Gmbh Selbstvernetzende Beschichtungszusammensetzungen auf Basis anorganischer fluorhaltiger Polykondensate
GB0002798D0 (en) * 2000-02-09 2000-03-29 Glaxo Group Ltd Actuator nozzle for metered dose inhaler
AU4417001A (en) 2000-03-01 2001-09-12 Glaxo Group Limited Metered dose inhaler
JP2003525090A (ja) 2000-03-01 2003-08-26 グラクソ グループ リミテッド 定量噴霧式吸入器
WO2001064275A1 (en) 2000-03-01 2001-09-07 Glaxo Group Limited Metered dose inhaler
EP1259429A2 (en) 2000-03-01 2002-11-27 Glaxo Group Limited Metered dose inhaler
US6696157B1 (en) * 2000-03-05 2004-02-24 3M Innovative Properties Company Diamond-like glass thin films
DE60141335D1 (de) * 2000-07-28 2010-04-01 Blue Medical Devices B V Intravaskulärer stent mit expandierbarer beschichtung
GB0025092D0 (en) 2000-10-13 2000-11-29 Glaxo Group Ltd Medicament dispenser
SE0004610D0 (sv) * 2000-12-13 2000-12-13 Astrazeneca Ab Surface modification process
NZ526564A (en) * 2000-12-22 2004-12-24 Glaxo Group Ltd Metered dose inhaler for salmeterol xinafoate
US20030148030A1 (en) * 2001-06-12 2003-08-07 Vernon Paul M. Barrier coatings for elastomeric materials
CA2449433A1 (en) * 2001-06-20 2003-01-03 Microvention, Inc. Medical devices having full or partial polymer coatings and their methods of manufacture
US20030031806A1 (en) * 2001-07-10 2003-02-13 Jinks Philip A. Medicinal inhalation devices and components coated using thermal chemical vapor deposition
GB0122725D0 (en) 2001-09-21 2001-11-14 Glaxo Group Ltd Drug dispensing components
US6649272B2 (en) * 2001-11-08 2003-11-18 3M Innovative Properties Company Coating composition comprising fluorochemical polyether silane polycondensate and use thereof
US6716534B2 (en) * 2001-11-08 2004-04-06 3M Innovative Properties Company Coating composition comprising a fluorochemical polyether silane partial condensate and use thereof
AU2002357789A1 (en) * 2001-12-07 2003-06-23 Glaxo Group Limited Metering valve and pharmaceutical metered dose inhaler and methods thereof
US6878419B2 (en) * 2001-12-14 2005-04-12 3M Innovative Properties Co. Plasma treatment of porous materials
SE0200313D0 (sv) * 2002-02-01 2002-02-01 Astrazeneca Ab Novel process
US20050133025A1 (en) * 2002-05-14 2005-06-23 Juha Laiho Inhalator and method of manufacturing same
JP4680597B2 (ja) 2002-09-06 2011-05-11 スリーエム イノベイティブ プロパティズ カンパニー エアゾール計量弁
US20040223916A1 (en) * 2003-02-20 2004-11-11 Burt Peter Colin Weston Canister for a metered dose inhaler
US7758936B2 (en) * 2003-09-18 2010-07-20 Boehringer Ingelheim Gmbh Pharmaceutical blister
GB0328502D0 (en) * 2003-12-10 2004-01-14 3M Innovative Properties Co Metered dose dispensers and assemblies therefor
JP5385146B2 (ja) 2006-10-20 2014-01-08 スリーエム イノベイティブ プロパティズ カンパニー 易洗浄基材のための方法及びそれによる物品
US8414956B2 (en) 2007-11-06 2013-04-09 3M Innovative Properties Company Medicinal inhalation devices and components thereof
GB0721737D0 (en) * 2007-11-06 2007-12-19 3M Innovative Properties Co Medicinal inhalation devices and components thereof
GB0721739D0 (en) * 2007-11-06 2007-12-19 3M Innovative Properties Co medicinal inhalation devices and components thereof
WO2010129753A1 (en) * 2009-05-06 2010-11-11 3M Innovative Properties Company Medicinal inhalation device

Also Published As

Publication number Publication date
US20100242958A1 (en) 2010-09-30
CA2704985A1 (en) 2009-05-14
EP2205303B1 (en) 2013-11-06
BRPI0817398A2 (pt) 2015-04-07
EP2205302A4 (en) 2010-12-29
JP5571560B2 (ja) 2014-08-13
BRPI0817384A2 (pt) 2015-03-31
WO2009061891A2 (en) 2009-05-14
CN101909682B (zh) 2013-09-18
CA2704997C (en) 2016-05-24
CA2704997A1 (en) 2009-05-14
WO2009061895A2 (en) 2009-05-14
JP2011502645A (ja) 2011-01-27
CN101909684B (zh) 2014-03-19
WO2009061891A3 (en) 2009-07-02
US8430097B2 (en) 2013-04-30
EP2205302A2 (en) 2010-07-14
CA2704985C (en) 2017-02-28
AU2008323920A1 (en) 2009-05-14
US20100247932A1 (en) 2010-09-30
EP2205303A4 (en) 2012-03-14
CN101909682A (zh) 2010-12-08
CN101909684A (zh) 2010-12-08
EP2205303A2 (en) 2010-07-14
US8808786B2 (en) 2014-08-19
WO2009061895A3 (en) 2009-07-16
AU2008323920B2 (en) 2012-12-20
AU2008323924A1 (en) 2009-05-14
AU2008323924B2 (en) 2013-01-17
US20130213395A1 (en) 2013-08-22
JP2011502646A (ja) 2011-01-27
US8414956B2 (en) 2013-04-09

Similar Documents

Publication Publication Date Title
JP5571561B2 (ja) 医薬品吸入装置及びそれらの構成要素
US8815325B2 (en) Medicinal inhalation device
EP2205300B1 (en) Medicinal inhalation devices and components thereof
EP2427278B1 (en) Medicinal inhalation devices and components thereof
US8616201B2 (en) Medicinal inhalation devices and components thereof
AU2010245834B2 (en) Medicinal inhalation device

Legal Events

Date Code Title Description
A521 Request for written amendment filed

Free format text: JAPANESE INTERMEDIATE CODE: A523

Effective date: 20111104

A621 Written request for application examination

Free format text: JAPANESE INTERMEDIATE CODE: A621

Effective date: 20111104

A131 Notification of reasons for refusal

Free format text: JAPANESE INTERMEDIATE CODE: A131

Effective date: 20130917

A601 Written request for extension of time

Free format text: JAPANESE INTERMEDIATE CODE: A601

Effective date: 20131216

A602 Written permission of extension of time

Free format text: JAPANESE INTERMEDIATE CODE: A602

Effective date: 20131224

A521 Request for written amendment filed

Free format text: JAPANESE INTERMEDIATE CODE: A523

Effective date: 20140317

TRDD Decision of grant or rejection written
A01 Written decision to grant a patent or to grant a registration (utility model)

Free format text: JAPANESE INTERMEDIATE CODE: A01

Effective date: 20140527

A61 First payment of annual fees (during grant procedure)

Free format text: JAPANESE INTERMEDIATE CODE: A61

Effective date: 20140626

R150 Certificate of patent or registration of utility model

Ref document number: 5571561

Country of ref document: JP

Free format text: JAPANESE INTERMEDIATE CODE: R150

LAPS Cancellation because of no payment of annual fees